![Almirall and Kaken Pharmaceutical enter into a license and distribution agreement for European rights to the topical formulation of efinaconazole Almirall and Kaken Pharmaceutical enter into a license and distribution agreement for European rights to the topical formulation of efinaconazole](https://mma.prnewswire.com/media/1217694/Almirall_Logo.jpg?p=twitter)
Almirall and Kaken Pharmaceutical enter into a license and distribution agreement for European rights to the topical formulation of efinaconazole
![Almirall and Bicosome collaborate to sublicense agreement for development of topical drugs - Hospital Pharmacy EuropeHospital Pharmacy Europe Almirall and Bicosome collaborate to sublicense agreement for development of topical drugs - Hospital Pharmacy EuropeHospital Pharmacy Europe](https://hospitalpharmacyeurope.com/wp-content/uploads/2017/07/Allergy-5.jpg)
Almirall and Bicosome collaborate to sublicense agreement for development of topical drugs - Hospital Pharmacy EuropeHospital Pharmacy Europe
![Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development | Business Wire Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development | Business Wire](https://mms.businesswire.com/media/20220131005182/en/1343114/5/Ablexis_logo_color_eps.jpg)
Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development | Business Wire
![Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development | Business Wire Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development | Business Wire](https://mms.businesswire.com/media/20220131005182/en/1342945/5/AlivaMab-DS-logo.jpg)